<SEC-DOCUMENT>0001140361-22-021173.txt : 20220531
<SEC-HEADER>0001140361-22-021173.hdr.sgml : 20220531
<ACCEPTANCE-DATETIME>20220531105807
ACCESSION NUMBER:		0001140361-22-021173
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220524
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220531
DATE AS OF CHANGE:		20220531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATLANTIC AMERICAN CORP
		CENTRAL INDEX KEY:			0000008177
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				581027114
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-03722
		FILM NUMBER:		22981328

	BUSINESS ADDRESS:	
		STREET 1:		4370 PEACHTREE RD NE
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30319
		BUSINESS PHONE:		4042665500

	MAIL ADDRESS:	
		STREET 1:		4370 PEACHTREE ROAD
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10038059_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:aame="http://atlam.com/20220524" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_74a6591d34794f04a7df799354f92c77" contextRef="c20220524to20220524" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_d24f48909f55493d9b75522b41a6a032" contextRef="c20220524to20220524">0000008177</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="aame-20220524.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220524to20220524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000008177</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-24</xbrli:startDate><xbrli:endDate>2022-05-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_4b808ca986cc4a92a0300ef656acae88" contextRef="c20220524to20220524">8-K</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Date of report (Date of earliest event reported)</div>
          </td>

    <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">May 31, 2022 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_6978224890d14ccfa1fe0138b61cd005" contextRef="c20220524to20220524" format="ixt:datemonthdayyearen">May 24, 2022</ix:nonNumeric>)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold; font-size: 24pt;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_4563323ed2d84047b4e0e7ca72cc2f0c" contextRef="c20220524to20220524">ATLANTIC AMERICAN CORPORATION</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_707136ee484d40f4ac3e86a26675f745" contextRef="c20220524to20220524" format="ixt-sec:stateprovnameen">Georgia</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_d73680a41b5f47bea3fe6f71d51ffeae" contextRef="c20220524to20220524">0-3722</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 33.33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_3efcf0c43e1e4430a60f3185bff66662" contextRef="c20220524to20220524">58-1027114</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">of incorporation)</div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Commission File Number)</div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 86%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_a370db8678f44685963ca78a5c51b0f6" contextRef="c20220524to20220524">4370 Peachtree Road, N.E.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_7c1bbd9f1cad4a51bfc33be4c40678e7" contextRef="c20220524to20220524">Atlanta</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_851fd735accd4516b4125f377eee65d5" contextRef="c20220524to20220524" format="ixt-sec:stateprovnameen">Georgia</ix:nonNumeric></div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 13.35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_e4ac2eef0c0b4dcbb7274fff4a8f6de6" contextRef="c20220524to20220524">30319</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 86%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">&#160;&#160;&#160;&#160;(Address of principal executive offices)</div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 13.35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54.7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
            <div style="text-align: left;">Registrant&#8217;s telephone number, including area code</div>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 44%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_43668d546f8d402d91406188a7ca894a" contextRef="c20220524to20220524">404</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_87aee2fd22214968b32afba08257f0bd" contextRef="c20220524to20220524">266-5500</ix:nonNumeric></div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">N/A</div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Former name or former address, if changed since last report)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 9pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_b41dccdf9771408aa3b7d6f5adbf738d" contextRef="c20220524to20220524" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 9pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_94d6d56f55d2455a84b3e467b9f5847a" contextRef="c20220524to20220524" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 9pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_62111a35c0b94b57a16a12054995a602" contextRef="c20220524to20220524" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 9pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_03fe0a1dbe1f4111a6f6c3a38bd94f26" contextRef="c20220524to20220524" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 1.9%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
          </td>

    <td style="width: 2.4%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 46%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_577f0f2bb91043db9f3ca0553813f03a" contextRef="c20220524to20220524">Common Stock, par value $1.00 per share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1.9%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_1a5b71a9da124841824c684739c9ee79" contextRef="c20220524to20220524">AAME</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2.4%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 46%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7ee2adac0843404695de13ea7dea712a" contextRef="c20220524to20220524" format="ixt-sec:exchnameen">NASDAQ Global Market</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2
      of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_d304819f6a2944dbaeacbab31fe200b0" contextRef="c20220524to20220524" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 45pt;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02.</div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
                  Officers.</div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On May 24, 2022, shareholders of Atlantic American Corporation (the &#8220;Company&#8221;) approved the Atlantic American Corporation 2022 Equity and Incentive Compensation Plan
        (the &#8220;Plan&#8221;), which had previously been adopted by the Company&#8217;s Board of Directors subject to shareholder approval. The Plan is described in Proposal No. 4 in the Company&#8217;s definitive proxy statement on Schedule 14A for the Company&#8217;s Annual
        Meeting of Shareholders held on Tuesday, May 24, 2022 (the &#8220;Annual Meeting&#8221;), which was filed with the Securities and Exchange Commission on April 13, 2022.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Plan is a summary only and is qualified in its entirety by reference to the full text of the Plan, a copy of which is attached hereto
        as Exhibit 10.1 and is incorporated herein by reference.</div>

      <div>&#160;</div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.07.</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Submission of Matters to a Vote of Security Holders.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Annual Meeting was held on Tuesday, May 24, 2022, at which the following matters were submitted to a vote of the shareholders, with voting results as set forth
      below:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(a) A vote regarding the election of six (6) directors of the Company to serve until the next annual meeting of shareholders and until their respective successors are
      duly elected and qualified:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td colspan="4" style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Shares Voted</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 22.64%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">For</span></div>
          </td>

    <td style="width: 23.11%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Withhold</span></div>
          </td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Broker Non-Vote</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; margin-left: 20.5pt;">Hilton H. Howell, Jr.</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">16,683,174</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">897,538</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; margin-left: 20.5pt;">Robin R. Howell</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">16,677,841</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">902,871</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; margin-left: 20.5pt;">Mark E. Preisinger</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">17,170,687</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">410,025</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; margin-left: 20.5pt;">Joseph M. Scheerer</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">17,143,475</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">437,237</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; margin-left: 20.5pt;">Scott G. Thompson</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">16,655,157</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">925,555</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; margin-left: 20.5pt;">D. Keehln Wheeler</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">17,170,982</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">409,730</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(b) A vote regarding the ratification of the appointment of Dixon Hughes Goodman LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year
      ending December 31, 2022:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td colspan="4" style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Shares Voted</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 22.64%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 23.11%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">For</span></div>
          </td>

    <td style="width: 22.64%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Against</span></div>
          </td>

    <td style="width: 23.11%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Abstain</span></div>
          </td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">18,590,813</div>
          </td>

    <td style="width: 22.64%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">80,205</div>
          </td>

    <td style="width: 23.11%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">9,683</div>
          </td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(c) An advisory vote regarding the compensation of the Company&#8217;s named executive officers:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td colspan="4" style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Shares Voted</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 22.64%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 23.11%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">For</span></div>
          </td>

    <td style="width: 22.64%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Against</span></div>
          </td>

    <td style="width: 23.11%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Abstain</span></div>
          </td>

    <td style="width: 24.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Broker Non-Vote</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.27%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">17,022,663</div>
          </td>

    <td style="width: 22.64%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">550,480</div>
          </td>

    <td style="width: 23.11%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">7,569</div>
          </td>

    <td style="width: 24.98%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) A vote regarding the approval of the Company&#8217;s 2022 Equity and Incentive Compensation Plan:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td colspan="4" style="width: 100%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Shares Voted</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 22.55%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 23.1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 25.02%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 29.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">For</span></div>
          </td>

    <td style="width: 22.55%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Against</span></div>
          </td>

    <td style="width: 23.1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Abstain</span></div>
          </td>

    <td style="width: 25.02%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><span style="text-decoration: underline;">Broker Non-Vote</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 29.33%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 22.55%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 23.1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 25.02%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 29.33%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">16,733,381</div>
          </td>

    <td style="width: 22.55%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">839,302</div>
          </td>

    <td style="width: 23.1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">8,029</div>
          </td>

    <td style="width: 25.02%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">1,099,989</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 45pt;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01. <br />
                </div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits.</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10.34%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
            </td>

    <td style="width: 0.62%; vertical-align: bottom;">&#160;</td>

    <td style="width: 89.04%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description of Exhibit</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10.34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10038059_ex10-1.htm">10.1</a></div>
            </td>

    <td style="width: 0.62%; vertical-align: bottom;">&#160;</td>

    <td style="width: 89.04%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Atlantic American Corporation 2022 Equity and Incentive Compensation Plan.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10.34%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 0.62%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 89.04%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10.34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104</div>
            </td>

    <td style="width: 0.62%; vertical-align: bottom;">&#160;</td>

    <td style="width: 89.04%; vertical-align: top;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
      undersigned, hereunto duly authorized.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">ATLANTIC AMERICAN CORPORATION</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
            <div style="text-align: left;">By:</div>
          </td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left;">/s/ J. Ross Franklin</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">J. Ross Franklin</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Vice President, Chief Financial Officer and Secretary</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Date:&#160; May 31, 2022</div>
          </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10038059_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt; font-family: 'Times New Roman';">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Exhibit 10.1<br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ATLANTIC AMERICAN CORPORATION</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022 EQUITY AND INCENTIVE COMPENSATION PLAN</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">1.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Purpose.&#160; </font>The purpose of this Plan<font style="font-family: 'Times New Roman'; color: rgb(31, 73, 125);">&#160;</font>is to permit award grants to non-employee
          directors, consultants, officers and other employees<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>of the Company and its Subsidiaries and to provide to such persons incentives and rewards for performance
          and/or service.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">2.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Definitions.&#160; </font>As used in this Plan:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Affiliate&#8221; means any corporation,
          partnership, joint venture or other entity, directly or indirectly, through one or more intermediaries, controlling, controlled by, or under common control with the Company as determined by the Committee or the Board, as applicable, in its
          discretion.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Appreciation Right&#8221; means a right
          granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 5</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Base Price&#8221; means the price to be
          used as the basis for determining the Spread upon the exercise of an Appreciation Right.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Board&#8221; means the Board of
          Directors of the Company.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Capital Stock&#8221; means all shares,
          options, warrants, general or limited partnership interests, membership interests or other equivalents (regardless of how designated) of or in a corporation, partnership, limited liability company or equivalent entity whether voting or nonvoting,
          including common stock, preferred stock or any other equity security.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Cash Incentive Award&#8221; means a
          cash award granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 8</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Change in Control&#8221; has the
          meaning set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 12</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Code&#8221; means the Internal Revenue
          Code of 1986, as amended, and the regulations thereunder, as such law and regulations may be amended from time to time.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Committee&#8221; means the Stock Option
          and Compensation Committee<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>of the Board (or its successor), or any other committee of the Board designated by the Board to administer this Plan pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 10</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Common Shares&#8221; means the common
          shares, par value $1.00 per share, of the Company or any security into which such common shares may be changed by reason of any transaction or event of the type referred to in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 11</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Company&#8221; means Atlantic American
          Corporation, a Georgia corporation, and its successors.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Continuing Directors&#8221; means the
          members of the Board on the Effective Date and each other director nominated for election or elected to the Board with the approval of a majority of the Continuing Directors who were members of the Board at the time of such nomination or
          election.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Date of Grant&#8221; means the date
          provided for by the Committee on which a grant of Option Rights, Appreciation Rights, Performance Shares, Performance Units, Cash Incentive Awards, or other awards contemplated by <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> of this Plan, or a grant or sale of Restricted Shares, Restricted Stock Units, or other awards contemplated by <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font>
          of this Plan, will become effective (which date will not be earlier than the date on which the Committee takes action with respect thereto).</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Detrimental Activity&#8221; means,
          unless otherwise set forth in an Evidence of Award or other agreement between the Company and a Participant:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z76102c2074e24e0088b32f89a09e0f59" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>engaging in any activity as an employee, principal, agent, or consultant for another entity that competes, directly or indirectly, with the Company in any actual, researched, or prospective product, service, system, or business activity
                for which the Participant has had any direct or indirect responsibility during the last two years of his or her employment with, or having acted as a consultant to, the Company or a Subsidiary (or such other period specified in an Evidence
                of Award), in any territory in which the Company or a Subsidiary sells, markets, services, or utilizes such product, service, or system, or engages in such business activity (or any portion of such territory or such other territory
                specified in the Evidence of Award);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze71c39efe04548c49338d668b1e8baac" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>soliciting any employee of the Company or a Subsidiary to terminate his or her employment with the Company or a Subsidiary;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z24e0df60096d483b9ecc3cfa22cfa07a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>the disclosure to anyone outside the Company or a Subsidiary, or the use in other than the Company&#8217;s or a Subsidiary&#8217;s business, without prior written authorization from the Company, of any confidential, proprietary or trade secret
                information or material relating to the business of the Company or its Subsidiaries, acquired by the Participant during his or her employment with the Company or its Subsidiaries or while acting as a director of or consultant for the
                Company or its Subsidiaries;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z16d57fd608b34af3b57b0d84e2128bfa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>the failure or refusal to disclose promptly and to assign to the Company upon request all right, title and interest in any invention or idea, patentable or not, made or conceived by the Participant during employment by, or while
                consulting with, the Company or any Subsidiary, relating in any manner to the actual or anticipated business, research or development work of the Company or any Subsidiary or the failure or refusal to do anything reasonably necessary to
                enable the Company or any Subsidiary to secure a patent where appropriate in the United States and in other countries;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zae4f3d673fed4c1a997a53945cc2296f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>activity that results in Termination for Cause. For the purposes of this Section, &#8220;Termination for Cause&#8221; will mean a termination:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3215769086174a2a82c7830e74d7dae6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 144pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(1)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>due to the Participant&#8217;s willful and continuous gross neglect of his or her duties for which he or she is employed; or</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze37a7a598e754e59bf0c50fbd4a68145" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 144pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(2)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>due to an act of dishonesty on the part of the Participant resulting or intended to result, directly or indirectly, in his or her gain for personal enrichment at the expense of the Company or a Subsidiary; or</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf9d81a1a574b4091b8bb5a9498209647" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(vi)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>any other conduct or act determined to be injurious, detrimental or prejudicial to any significant interest of the Company or any Subsidiary unless the Participant acted in good faith and in a manner he or she reasonably believed to be
                in or not opposed to the best interests of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Director&#8221; means a member of the
          Board.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Effective Date&#8221; means the date
          this Plan is approved by the Shareholders.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Evidence of Award&#8221; means an
          agreement, certificate, resolution or other type or form of writing or other evidence approved by the Committee that sets forth the terms and conditions of the awards granted under this Plan.&#160; An Evidence of Award may be in an electronic medium,
          may be limited to notation on the books and records of the Company and, unless otherwise determined by the Committee, need not be signed by a representative of the Company or a Participant.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Exchange Act&#8221; means the
          Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Incentive Stock Option&#8221; means an
          Option Right that is intended to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code or any successor provision.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Management Objectives&#8221; means the
          performance objective or objectives established pursuant to this Plan for Participants who have received grants of Performance Shares, Performance Units or Cash Incentive Awards or, when so determined by the Committee, Option Rights, Appreciation
          Rights, Restricted Shares, Restricted Stock Units, dividend equivalents or other awards pursuant to this Plan.&#160; The Management Objectives applicable to an award under this Plan (if any) shall be determined by the Committee, and may be based on
          one or more, or a combination, of metrics under the following categories or such other metrics as may be determined by the Committee (including relative or growth achievement regarding such metrics):</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9e42cff527c34271854382c6953ce169" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Profits (e.g., operating income, underwriting income, EBIT, EBT, net income, earnings per share, residual or economic earnings, economic profit &#8212; these profitability metrics could be, but are not required to be, measured or subject to
                GAAP definition);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zff5e185d2e764b82a5caae9c7d3f06e1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Cash Flow (e.g., EBITDA, free cash flow, free cash flow with or without specific capital expenditure target or range, including or excluding divestments and/or acquisitions, total cash flow, cash flow in excess of cost of capital or
                residual cash flow or cash flow return on investment);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2c8237d669744122a873759cdda0e756" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Returns (e.g., Profits or Cash Flow returns on: assets, invested capital, net capital employed, and equity);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4a714ca9f69348c99c142c0a77e388c6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Liquidity Measures (e.g., debt-to-capital, debt-to-EBITDA, total debt ratio);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6eb6378b86ca4161a80c56d65f6c6db0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Premium Growth, Underwriting Margin Growth, Cost Initiative and Stock Price Metrics (e.g., premiums earned, total revenues, revenue growth, underwriting margin and underwriting margin growth, material margin and material margin growth,
                stock price appreciation, and total return to shareholders); and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7937153a20da4627967e4408f0653df7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(vi)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Strategic Initiative Key Deliverable Metrics consisting of one or more of the following: product development, strategic partnering, research and development, vitality index, market penetration, geographic business expansion goals, cost
                targets, customer satisfaction, employee satisfaction, management of employment practices and employee benefits, supervision of litigation and information technology, and goals relating to acquisitions or divestitures of subsidiaries,
                affiliates and joint ventures.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner
        in which it conducts its business, or other events or circumstances render the Management Objectives unsuitable, the Committee may in its discretion modify such Management Objectives or the goals or actual levels of achievement regarding the
        Management Objectives, in whole or in part, as the Committee deems appropriate and equitable.</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Market Value per Share&#8221; means, as
          of any particular date, the closing price of a Common Share as reported for that date on the NASDAQ Stock Market or, if the Common Shares are not then listed on the NASDAQ Stock Market, on any other national securities exchange on which the
          Common Shares are listed, or if there are no sales on such date, on the next preceding trading day during which a sale occurred.&#160; If there is no regular public trading market for the Common Shares, then the Market Value per Share shall be the
          fair market value as determined in good faith by the Committee.&#160; The Committee is authorized to adopt another fair market value pricing method provided such method is stated in the applicable Evidence of Award and is in compliance with the fair
          market value pricing rules set forth in Section 409A of the Code.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Optionee&#8221; means the optionee
          named in an Evidence of Award evidencing an outstanding Option Right.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Option Price&#8221; means the purchase
          price payable on exercise of an Option Right.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Option Right&#8221; means the right to
          purchase Common Shares upon exercise of an award granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 4</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Participant&#8221; means a person who
          is selected by the Committee to receive benefits under this Plan and who is at the time (i) a non-employee Director, (ii) an officer or other employee of the Company or any Subsidiary, including a person who has agreed to commence serving in such
          capacity within 90 days of the Date of Grant, or (iii) a person, including a consultant, who provides services to the Company or any Subsidiary that are equivalent to those typically provided by an employee (provided that such person satisfies
          the Form S-8 definition of an &#8220;employee&#8221;).</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Performance Period&#8221; means, in
          respect of a Cash Incentive Award, Performance Share or Performance Unit, a period of time established pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 8</u></font> of this Plan within which the
          Management Objectives relating to such Cash Incentive Award, Performance Share or Performance Unit are to be achieved.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Performance Share&#8221; means a
          bookkeeping entry that records the equivalent of one Common Share awarded pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 8</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Performance Unit&#8221; means a
          bookkeeping entry awarded pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 8</u></font> of this Plan that records a unit equivalent to $1.00 or such other value as is determined by the Committee.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Permitted Holder&#8221; means: (i) the
          estate of J. Mack Robinson; (ii) Harriet J. Robinson and her lineal descendants and spouses of her lineal descendants, and Hilton H. Howell, Jr. and his lineal descendants and spouses of his lineal descendants; (iii) in the event of the
          incompetence or death of any of the Persons described in clause (ii), such Person&#8217;s estate, executor, administrator, committee or other personal representative; (iv) any trusts created for the benefit of the Persons described in clause (i) or
          (ii); (v) any Person controlled by any of the Persons described in clause (i), (ii), (iii) or (iv); and (vi) any group of Persons (as defined in the Exchange Act) in which the Persons described in clause (i), (ii), (iii), (iv) or (v),
          individually or collectively, control such group.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Plan&#8221; means this Atlantic American
          Corporation 2022 Equity and Incentive Compensation Plan, as may be amended or amended and restated from time to time.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Predecessor Plan&#8221; means the
          Atlantic American Corporation 2012 Equity Incentive Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Predecessor Plan Termination
          Date&#8221; means May 1, 2022.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Restricted Shares&#8221; means Common
          Shares granted or sold pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 6</u></font> of this Plan as to which neither the substantial risk of forfeiture nor the prohibition on transfer has
          expired.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Restricted Stock Units&#8221; means an
          award made pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 7</u></font> of this Plan of the right to receive Common Shares, cash or a combination thereof at the end of the applicable Restriction
          Period.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Restriction Period&#8221; means the
          period of time during which Restricted Stock Units are subject to restrictions, as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 7</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Shareholder&#8221; means an individual
          or entity that owns one or more Common Shares.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Spread&#8221; means the excess of the
          Market Value per Share on the date when an Appreciation Right is exercised over the Base Price provided for with respect to the Appreciation Right.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Subsidiary&#8221; means a corporation,
          company or other entity (i) more than 50% of whose outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) are, or (ii) which does not have outstanding shares or securities (as
          may be the case in a partnership, joint venture, limited liability company, unincorporated association or other similar entity), but more than 50% of whose ownership interest representing the right generally to make decisions for such other
          entity is, now or hereafter, owned or controlled, directly or indirectly, by the Company; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>,
          that for purposes of determining whether any person may be a Participant for purposes of any grant of Incentive Stock Options, &#8220;Subsidiary&#8221; means any corporation in which the Company at the time owns or controls, directly or indirectly, more than
          50% of the total combined Voting Power represented by all classes of stock issued by such corporation.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(mm)&#160;&#160;&#160;&#160; &#8220;Voting Power&#8221; means, at any time, the
          combined voting power of the then-outstanding securities entitled to vote generally in the election of Directors in the case of the Company, or members of the board of directors or similar body in the case of another entity.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">3.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Shares Available Under this Plan.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Maximum Shares Available Under this Plan</u></font>.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfb90b501c61743be98f28d616cd77faf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Subject to adjustment as provided in <font style="font-weight: bold;"><u>Section 11</u></font> of this Plan and the share counting rules set forth in <font style="font-weight: bold;"><u>Section 3(b)</u></font> of this Plan, the number
                of Common Shares available under this Plan for awards of (A) Option Rights or Appreciation Rights, (B) Restricted Shares, (C) Restricted Stock Units, (D) Performance Shares or Performance Units, (E) awards contemplated by <font style="font-weight: bold;"><u>Section 9</u></font> of this Plan, or (F) dividend equivalents paid with respect to awards made under this Plan<font style="color: rgb(31, 73, 125);">&#160;</font>will not exceed in the aggregate (x) 3,000,000
                Common Shares, plus (y) the Common Shares that are subject to awards granted under this Plan or the Predecessor Plan that are added (or added back, as applicable) to the aggregate number of Common Shares available under this <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font> pursuant to the share counting rules of this Plan.&#160; Such shares may be shares of original issuance or treasury shares or a combination of the foregoing.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z381b1c19c2d445a8ae752762573a076c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Subject to the share counting rules set forth in <font style="font-weight: bold;"><u>Section 3(b)</u></font> of this Plan, the aggregate number of Common Shares available under <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font>
                of this Plan will be reduced by one Common Share for every one Common Share subject to an award granted under this Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Share Counting Rules</u></font>.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z17e7b4e3fe134ab7a1b3efd50b5de565" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Except as provided in <font style="font-weight: bold;"><u>Section 22</u></font> of this Plan, if any award granted under this Plan (in whole or in part) is cancelled or forfeited, expires, is settled for cash, or is unearned, the Common
                Shares subject to such award will, to the extent of such cancellation, forfeiture, expiration, cash settlement, or unearned amount, again be available under <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font> above.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf6570e7ab52745bf8cb94a5ef1a2e7c0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>If, <font style="color: rgb(0, 0, 0);">on or after the Predecessor Plan Termination Date</font>, any Common Shares subject to an award granted under the Predecessor Plan are forfeited, or an award granted under the Predecessor Plan (in
                whole or in part) is cancelled or forfeited, expires, is settled for cash, or is unearned, the Common Shares subject to such award will, to the extent of such cancellation, forfeiture, expiration, cash settlement, or unearned amount, be
                available for awards under this Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z94103b2afa1e4f11ba74095ebe4c988b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0);">Notwithstanding anything to the contrary contained in this Plan: (A) Common Shares withheld by the Company, tendered or otherwise used in payment of the Option Price of an Option Right (or the option price of
                an option granted under the Predecessor Plan) will not be added (or added back, as applicable) to the aggregate number of Common Shares available under <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font> of this Plan; (B) Common
                Shares withheld by the Company, tendered or otherwise used to satisfy tax withholding with respect to awards will not be added (or added back, as applicable) to the aggregate number of Common Shares available under <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font> of this Plan; (C) Common Shares subject to a share-settled Appreciation Right that are not actually issued in connection with the settlement of such Appreciation Right on the
                exercise thereof will not be added (or added back, as applicable) to the aggregate number of Common Shares available under <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font> of this Plan; and (D) Common Shares reacquired by the
                Company on the open market or otherwise using cash proceeds from the exercise of Option Rights will not be added (or added back, as applicable) to the aggregate number of Common Shares available under <font style="font-weight: bold;"><u>Section
                    3(a)(i)</u></font> of this Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z4732829cfbab4756b3114569482581ca" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0);">If, under this Plan, a Participant has elected to give up the right to receive compensation in exchange for Common Shares based on fair market value, such Common Shares will not count against the aggregate
                limit under <font style="font-weight: bold;"><u>Section 3(a)(i)</u></font> of this Plan.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Limit on Incentive Stock Options</u></font>.&#160; Notwithstanding anything to the contrary contained in this Plan, and subject to adjustment as provided in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 11</u></font> of this Plan, the aggregate number of Common Shares actually issued or transferred by the Company upon the exercise of Incentive Stock Options will not exceed 3,000,000 Common Shares.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Non-Employee Director Compensation Limit</u></font>.&#160; Notwithstanding anything to the contrary contained in this Plan, in no event will any non-employee Director in any one calendar year be granted compensation
          for such service having an aggregate maximum value (measured at the Date of Grant as applicable, and calculating the value of any awards based on the grant date fair value for financial reporting purposes) in excess of $500,000.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">4.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Option Rights.&#160; </font>The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the granting to Participants of Option Rights.&#160;
          Each such grant may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant will specify the number
          of Common Shares to which it pertains subject to the limitations set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 3</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant will specify an Option
          Price per Common Share, which Option Price (except with respect to awards under <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 22</u></font> of this Plan) may not be less than the Market Value per Share on
          the Date of Grant.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant will specify whether
          the Option Price will be payable (i) in cash, by check acceptable to the Company or by wire transfer of immediately available funds, (ii) by the actual or constructive transfer to the Company of Common Shares owned by the Optionee having a value
          at the time of exercise equal to the total Option Price, (iii) subject to any conditions or limitations established by the Committee, by the withholding of Common Shares otherwise issuable upon exercise of an Option Right pursuant to a &#8220;net
          exercise&#8221; arrangement (it being understood that, solely for purposes of determining the number of treasury shares held by the Company, the Common Shares so withheld will not be treated as issued and acquired by the Company upon such exercise),
          (iv) by a combination of such methods of payment, or (v) by such other methods as may be approved by the Committee.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent permitted by law,
          any grant may provide for deferred payment of the Option Price from the proceeds of sale through a bank or broker on a date satisfactory to the Company of some or all of the Common Shares to which such exercise relates.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant will specify the period
          or periods of continuous service by the Optionee with the Company or any Subsidiary, if any, that is necessary before any Option Rights or installments thereof will vest.&#160; Option Rights may provide for continued vesting or the earlier vesting of
          such Option Rights, including in the event of the retirement, death, disability or termination of employment or service of a Participant or in the event of a Change in Control.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any grant of Option Rights may
          specify Management Objectives regarding the vesting of such rights.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Option Rights granted under this
          Plan may be (i) options, including Incentive Stock Options, that are intended to qualify under particular provisions of the Code, (ii) options that are not intended to so qualify, or (iii) combinations of the foregoing.&#160; Incentive Stock Options
          may only be granted to Participants who meet the definition of &#8220;employees&#8221; under Section 3401(c) of the Code.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Option Right will be
          exercisable more than 10 years from the Date of Grant.&#160; The Committee may provide in any Evidence of Award for the automatic exercise of an Option Right upon such terms and conditions as established by the Committee.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Option Rights granted under this
          Plan may not provide for any dividends or dividend equivalents thereon.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant of Option Rights will
          be evidenced by an Evidence of Award.&#160; Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">5.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;">Appreciation Rights.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may, from time to
          time and upon such terms and conditions as it may determine, authorize the granting to any Participant of Appreciation Rights.&#160; An Appreciation Right will be the right of the Participant to receive from the Company an amount determined by the
          Committee, which will be expressed as a percentage of the Spread (not exceeding 100%) at the time of exercise.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant of Appreciation Rights
          may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z93cd0a21e1a3498f85d9660f9e98a352" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Each grant may specify that the amount payable on exercise of an Appreciation Right will be paid by the Company in cash, Common Shares or any combination thereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb98f81e83ca8415889d665beaed49a73" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Each grant will specify the period or periods of continuous service by the Participant with the Company or any Subsidiary, if any, that is necessary before the Appreciation Rights or installments thereof will vest.&#160; Appreciation Rights
                may provide for continued vesting or the earlier vesting of such Appreciation Rights, including in the event of the retirement, death, disability or termination of employment or service of a Participant or in the event of a Change in
                Control.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z12ec726c644c4c2d816a7c708820e019" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Any grant of Appreciation Rights may specify Management Objectives regarding the vesting of such Appreciation Rights.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcad09e5877da48b4af79012baa8b43e9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Appreciation Rights granted under this Plan may not provide for any dividends or dividend equivalents thereon.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2a55789f7fc2495aad866da0f5788303" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Each grant of Appreciation Rights will be evidenced by an Evidence of Award.&#160; Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Also, regarding Appreciation
          Rights:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4620971f0e8f4d46b6e204e07196d999" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>Each grant will specify in respect of each Appreciation Right a Base Price, which (except with respect to awards under <font style="font-weight: bold;"><u>Section 22</u></font> of this Plan) may not be less than the Market Value per
                Share on the Date of Grant; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z80f7a8adebf94c128d33901803d53dae" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; font-size: 10pt; font-family: 'Times New Roman';"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt; font-family: 'Times New Roman';">
              <div>No Appreciation Right granted under this Plan may be exercised more than 10 years from the Date of Grant.&#160; The Committee may provide in any Evidence of Award for the automatic exercise of an Appreciation Right upon such terms and
                conditions as established by the Committee.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">6.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Restricted Shares.&#160; </font>The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the grant or sale of Restricted Shares to
          Participants.&#160; Each such grant or sale may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such grant or sale will
          constitute an immediate transfer of the ownership of Common Shares to the Participant in consideration of the performance of services, entitling such Participant to voting, dividend and other ownership rights (subject in particular to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 6(g)</u></font> of this Plan), but subject to the substantial risk of forfeiture and restrictions on transfer hereinafter described.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such grant or sale may be
          made without additional consideration or in consideration of a payment by such Participant that is less than the Market Value per Share on the Date of Grant.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such grant or sale will
          provide that the Restricted Shares covered by such grant or sale will be subject to a &#8220;substantial risk of forfeiture&#8221; within the meaning of Section 83 of the Code for a period to be determined by the Committee on the Date of Grant or until
          achievement of Management Objectives referred to in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 6(e)</u></font> of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such grant or sale will
          provide that during or after the period for which such substantial risk of forfeiture is to continue, the transferability of the Restricted Shares will be prohibited or restricted in the manner and to the extent prescribed by the Committee on the
          Date of Grant (which restrictions may include rights of repurchase or first refusal of the Company or provisions subjecting the Restricted Shares to a continuing substantial risk of forfeiture while held by any transferee).</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any grant of Restricted Shares may
          specify Management Objectives regarding the vesting of such Restricted Stock.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything to the
          contrary contained in this Plan, Restricted Shares may provide for continued vesting or the earlier vesting of such Restricted Shares, including in the event of the retirement, death, disability or termination of employment or service of a
          Participant or in the event of a Change in Control.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any such grant or sale of
          Restricted Shares may require that any and all dividends or other distributions paid thereon during the period of such restrictions be automatically deferred and/or reinvested in additional Restricted Shares, which will be subject to the same
          restrictions as the underlying award.&#160; For the avoidance of doubt, any such dividends or other distributions on Restricted Shares will be deferred until, and paid contingent upon, the vesting of such Restricted Shares.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant or sale of Restricted
          Shares will be evidenced by an Evidence of Award.&#160; Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.&#160; Unless otherwise directed by the
          Committee, (i) all certificates representing Restricted Shares will be held in custody by the Company until all restrictions thereon will have lapsed, together with a stock power or powers executed by the Participant in whose name such
          certificates are registered, endorsed in blank and covering such shares or (ii) all Restricted Shares will be held at the Company&#8217;s transfer agent in book entry form with appropriate restrictions relating to the transfer of such Restricted
          Shares.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">7.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Restricted Stock Units.&#160; </font>The Committee may, from time to time and upon such terms and conditions as it may determine, authorize the granting or sale of Restricted
          Stock Units to Participants.&#160; Each such grant or sale may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such grant or sale will
          constitute the agreement by the Company to deliver Common Shares or cash, or a combination thereof, to the Participant in the future in consideration of the performance of services, but subject to the fulfillment of such conditions (which may
          include achievement regarding Management Objectives) during the Restriction Period as the Committee may specify.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each such grant or sale may be
          made without additional consideration or in consideration of a payment by such Participant that is less than the Market Value per Share on the Date of Grant.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything to the
          contrary contained in this Plan, Restricted Stock Units may provide for continued vesting or the earlier lapse or other modification of the Restriction Period, including in the event of the retirement, death, disability or termination of
          employment or service of a Participant or in the event of a Change in Control.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the Restriction Period, the
          Participant will have no right to transfer any rights under his or her award and will have no rights of ownership in the Common Shares deliverable upon payment of the Restricted Stock Units and will have no right to vote them, but the Committee
          may, at or after the Date of Grant, authorize the payment of dividend equivalents on such Restricted Stock Units on a deferred and contingent basis, either in cash or in additional Common Shares; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that dividend equivalents or other distributions on Common Shares underlying Restricted Stock Units shall be deferred until,
          and paid contingent upon, the vesting of such Restricted Stock Units.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant or sale of Restricted
          Stock Units will specify the time and manner of payment of the Restricted Stock Units that have been earned.&#160; Each grant or sale will specify that the amount payable with respect thereto will be paid by the Company in Common Shares or cash, or a
          combination thereof.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant or sale of Restricted
          Stock Units will be evidenced by an Evidence of Award.&#160; Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">8.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Cash Incentive Awards, Performance Shares and Performance Units.&#160; </font>The Committee may, from time to time and upon such terms and conditions as it may determine,
          authorize the granting of Cash Incentive Awards, Performance Shares and Performance Units.&#160; Each such grant may utilize any or all of the authorizations, and will be subject to all of the requirements, contained in the following provisions:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant will specify the number
          or amount of Performance Shares or Performance Units, or amount payable with respect to a Cash Incentive Award, to which it pertains, which number or amount may be subject to adjustment to reflect changes in compensation or other factors.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Performance Period with
          respect to each Cash Incentive Award or grant of Performance Shares or Performance Units will be such period of time as will be determined by the Committee, which may be subject to continued vesting or earlier lapse or other modification,
          including in the event of the retirement, death, disability or termination of employment or service of a Participant or in the event of a Change in Control.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant of a Cash Incentive
          Award, Performance Shares or Performance Units will specify Management Objectives regarding the earning of the award.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant will specify the time
          and manner of payment of a Cash Incentive Award, Performance Shares or Performance Units that have been earned.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may, on the Date of
          Grant of Performance Shares or Performance Units, provide for the payment of dividend equivalents to the holder thereof either in cash or in additional Common Shares, which dividend equivalents will be subject to deferral and payment on a
          contingent basis based on the Participant&#8217;s earning and vesting of the Performance Shares or Performance Units, as applicable, with respect to which such dividend equivalents are paid.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant of a Cash Incentive
          Award, Performance Shares or Performance Units will be evidenced by an Evidence of Award.&#160; Each Evidence of Award will be subject to this Plan and will contain such terms and provisions, consistent with this Plan, as the Committee may approve.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">9.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;">Other Awards.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to applicable law and the
          applicable limits set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 3</u></font> of this Plan, the Committee may authorize the grant to any Participant of Common Shares or such other awards that
          may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Common Shares or factors that may influence the value of such shares, including, without limitation, convertible or exchangeable
          debt securities, other rights convertible or exchangeable into Common Shares, purchase rights for Common Shares, awards with value and payment contingent upon performance of the Company or specified Subsidiaries, affiliates or other business
          units thereof or any other factors designated by the Committee, and awards valued by reference to the book value of the Common Shares or the value of securities of, or the performance of specified Subsidiaries or affiliates or other business
          units of the Company.&#160; The Committee will determine the terms and conditions of such awards.&#160; Common Shares delivered pursuant to an award in the nature of a purchase right granted under this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> will be purchased for such consideration, paid for at such time, by such methods, and in such forms, including, without limitation, Common Shares, other awards, notes or other property,
          as the Committee determines.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cash awards, as an element of or
          supplement to any other award granted under this Plan, may also be granted pursuant to this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font>.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may authorize the
          grant of Common Shares as a bonus, or may authorize the grant of other awards in lieu of obligations of the Company or a Subsidiary to pay cash or deliver other property under this Plan or under other plans or compensatory arrangements, subject
          to such terms as will be determined by the Committee in a manner that complies with Section 409A of the Code.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may, at or after the
          Date of Grant, authorize the payment of dividends or dividend equivalents on awards granted under this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> on a deferred and contingent basis, either
          in cash or in additional Common Shares; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that dividend equivalents or other
          distributions on Common Shares underlying awards granted under this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> shall be deferred until, and paid contingent upon, the earning and vesting of
          such awards.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each grant of an award under this
          <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> will be evidenced by an Evidence of Award.&#160; Each such Evidence of Award will be subject to this Plan and will contain such terms and provisions,
          consistent with this Plan, as the Committee may approve, and will specify the time and terms of delivery of the applicable award.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything to the
          contrary contained in this Plan, awards under this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> may provide for the earning or vesting of, or earlier elimination of restrictions applicable
          to, such award, including in the event of the retirement, death, disability or termination of employment or service of a Participant or in the event of a Change in Control.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">10.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Administration of this Plan.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Plan will be administered by
          the Committee; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that, at the discretion of the Board, this Plan may be administered by
          the Board, including with respect to the administration of any responsibilities and duties held by the Committee hereunder.&#160; The Committee may from time to time delegate all or any part of its authority under this Plan to a subcommittee thereof.&#160;
          To the extent of any such delegation, references in this Plan to the Committee will be deemed to be references to such subcommittee.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The interpretation and
          construction by the Committee of any provision of this Plan or of any Evidence of Award (or related documents) and any determination by the Committee pursuant to any provision of this Plan or of any such agreement, notification or document will
          be final and conclusive.&#160; No member of the Committee shall be liable for any such action or determination made in good faith.&#160; In addition, the Committee is authorized to take any action it determines in its sole discretion to be appropriate
          subject only to the express limitations contained in this Plan, and no authorization in any Plan section or other provision of this Plan is intended or may be deemed to constitute a limitation on the authority of the Committee.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent permitted by law,
          the Committee may delegate to one or more of its members, to one or more officers of the Company, or to one or more agents or advisors, such administrative duties or powers as it may deem advisable, and the Committee, the subcommittee, or any
          person to whom duties or powers have been delegated as aforesaid, may employ one or more persons to render advice with respect to any responsibility the Committee, the subcommittee or such person may have under this Plan.&#160; The Committee may, by
          resolution, authorize one or more officers of the Company to do one or both of the following on the same basis as the Committee:&#160; (i) designate employees to be recipients of awards under this Plan; and (ii) determine the size of any such awards;
          <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that (A) the Committee will not delegate such responsibilities to any such officer for
          awards granted to an employee who is an officer (for purposes of Section 16 of the Exchange Act), Director, or more than 10% &#8220;beneficial owner&#8221; (as such term is defined in Rule 13d-3 promulgated under the Exchange Act) of any class of the
          Company&#8217;s equity securities that is registered pursuant to Section 12 of the Exchange Act, as determined by the Committee in accordance with Section 16 of the Exchange Act; (B) the resolution providing for such authorization shall set forth the
          total number of Common Shares such officer(s) may grant; and (C) the officer(s) will report periodically to the Committee regarding the nature and scope of the awards granted pursuant to the authority delegated.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">11.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">Adjustments.&#160; </font>The Committee shall make or provide for such adjustments in the number of and kind of Common Shares covered by outstanding Option Rights, Appreciation
          Rights, Restricted Shares, Restricted Stock Units, Performance Shares and Performance Units granted hereunder and, if applicable, in the number of and kind of Common Shares covered by other awards granted pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> of this Plan, in the Option Price and Base Price provided in outstanding Option Rights and Appreciation Rights, respectively, in Cash Incentive Awards, and in other award
          terms, as the Committee, in its sole discretion, determines in good faith is equitably required to prevent dilution or enlargement of the rights of Participants that otherwise would result from (a) any extraordinary cash dividend, stock dividend,
          stock split, combination of shares, recapitalization or other change in the capital structure of the Company, (b) any merger, consolidation, spin-off, split-off, spin-out, split-up, reorganization, partial or complete liquidation or other
          distribution of assets, issuance of rights or warrants to purchase securities, or (c) any other corporate transaction or event having an effect similar to any of the foregoing.&#160; Moreover, in the event of any such transaction or event or in the
          event of a Change in Control, the Committee may provide in substitution for any or all outstanding awards under this Plan such alternative consideration (including cash), if any, as it, in good faith, may determine to be equitable in the
          circumstances and shall require in connection therewith the surrender of all awards so replaced in a manner that complies with Section 409A of the Code.&#160; In addition, for each Option Right or Appreciation Right with an Option Price or Base Price,
          respectively, greater than the consideration offered in connection with any such transaction or event or Change in Control, the Committee may in its discretion elect to cancel such Option Right or Appreciation Right without any payment to the
          person holding such Option Right or Appreciation Right.&#160; The Committee shall also make or provide for such adjustments in the number of Common Shares specified in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section
              3</u></font> of this Plan as the Committee, in its sole discretion, determines in good faith is appropriate to reflect any transaction or event described in this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section
              11</u></font>; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that any such adjustment to the number specified in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 3(c)</u></font> of this Plan will be made only if and to the extent that such adjustment would not cause any Option Right intended to qualify as an Incentive Stock
          Option to fail to so qualify.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">12.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Change in Control</font>.&#160; For purposes of this Plan, except as may be otherwise prescribed by the Committee in an Evidence of Award made under this Plan, a &#8220;Change in
          Control&#8221; will be deemed to have occurred upon the occurrence (after the Effective Date) of one or more of the following events:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the acquisition of ownership,
          directly or indirectly, beneficially or of record, by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a &#8220;Person&#8221;) other than any Permitted Holder of more than 50% of the outstanding shares
          of the voting equity interests of the Company; or</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;during any period of 24
          consecutive months, a majority of the members of the Board or other equivalent governing body of the Company cease to be composed of individuals who are Continuing Directors.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">13.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Detrimental Activity and Recapture Provisions</font>.&#160; Any Evidence of Award may reference a clawback policy of the Company or provide for the cancellation or forfeiture of an
          award or the forfeiture and repayment to the Company of any gain related to an award, or other provisions intended to have a similar effect, upon such terms and conditions as may be determined by the Committee from time to time, if a Participant,
          either (a) during employment or other service with the Company or a Subsidiary, or (b) within a specified period after termination of such employment or service, engages in any detrimental activity, as described in the definition of &#8220;Detrimental
          Activity&#8221; in this Plan, in the applicable Evidence of Award, or in such clawback policy.&#160; In addition, notwithstanding anything in this Plan to the contrary, any Evidence of Award or such clawback policy may also provide for the cancellation or
          forfeiture of an award or the forfeiture and repayment to the Company of any Common Shares issued under and/or any other benefit related to an award, or other provisions intended to have a similar effect, including upon such terms and conditions
          as may be required by the Committee or under Section 9D of the Exchange Act and any applicable rules or regulations promulgated by the Securities and Exchange Commission or any national securities exchange or national securities association on
          which the Common Shares may be traded.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">15</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">14.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Accommodations for Participants of Different Nationalities.</font>&#160; In order to facilitate the making of any grant or combination of grants under this Plan, the Committee may
          provide for such special terms for awards to Participants as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy or custom given that Participants are expected to be nationals of both the United
          States of America and other countries, or to be employed by the Company or any Subsidiary both within and outside of the United States of America.&#160; Moreover, the Committee may approve such supplements to or amendments, restatements or alternative
          versions of this Plan (including sub-plans) (to be considered part of this Plan) as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of this Plan as in effect for any other purpose, and the Secretary
          or other appropriate officer of the Company may certify any such document as having been approved and adopted in the same manner as this Plan.&#160; No such special terms, supplements, amendments or restatements, however, will include any provisions
          that are inconsistent with the terms of this Plan as then in effect unless this Plan could have been amended to eliminate such inconsistency without further approval by the Shareholders.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">15.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Transferability.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';"><a name="z_DV_M23"></a>(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as otherwise determined by the Committee, and subject to compliance with <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 17(b)</u></font> of this Plan and Section 409A of the Code, no Option Right, Appreciation Right, Restricted Shares, Restricted Stock Unit, Performance Share,
        Performance Unit, Cash Incentive Award, award contemplated by <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> of this Plan or dividend equivalents paid with respect to awards made under this Plan
        will be transferable by the Participant except by will or the laws of descent and distribution. In no event will any such award granted under this Plan be transferred for value.&#160; Where transfer is permitted, references to &#8220;Participant&#8221; shall be
        construed, as the Committee deems appropriate, to include any permitted transferee to whom such award is transferred.&#160; Except as otherwise determined by the Committee, Option Rights and Appreciation Rights will be exercisable during the
        Participant&#8217;s lifetime only by him or her or, in the event of the Participant&#8217;s legal incapacity to do so, by his or her guardian or legal representative acting on behalf of the Participant in a fiduci<a name="z_DV_C26"></a>ary capacity under state
        law or c<a name="z_DV_M25"></a>ourt supervision<a name="z_DV_C27"></a>.</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may specify on the
          Date of Grant that part or all of the Common Shares that are (i) to be issued or transferred by the Company upon the exercise of Option Rights or Appreciation Rights, upon the termination of the Restriction Period applicable to Restricted Stock
          Units or upon payment under any grant of Performance Shares or Performance Units or (ii) no longer subject to the substantial risk of forfeiture and restrictions on transfer referred to in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 6</u></font> of this Plan, will be subject to further restrictions on transfer, including minimum holding periods.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">16</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">16.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Withholding Taxes.</font>&#160; To the extent that the Company is required to withhold federal, state, local or foreign taxes or other amounts in connection with any payment made
          or benefit realized by a Participant or other person under this Plan, and the amounts available to the Company for such withholding are insufficient, it will be a condition to the receipt of such payment or the realization of such benefit that
          the Participant or such other person make arrangements satisfactory to the Company for payment of the balance of such taxes or other amounts required to be withheld, which arrangements (in the discretion of the Committee) may include
          relinquishment of a portion of such benefit.&#160; If a Participant&#8217;s benefit is to be received in the form of Common Shares, and such Participant fails to make arrangements for the payment of taxes or other amounts, then, unless otherwise determined
          by the Committee, the Company will withhold Common Shares having a value equal to the amount required to be withheld.&#160; Notwithstanding the foregoing, when a Participant is required to pay the Company an amount required to be withheld under
          applicable income, employment, tax or other laws, the Committee may require the Participant to satisfy the obligation, in whole or in part, by having withheld, from the Common Shares delivered or required to be delivered to the Participant,
          Common Shares having a value equal to the amount required to be withheld or by delivering to the Company other Common Shares held by such Participant.&#160; The Common Shares used for tax or other withholding will be valued at an amount equal to the
          fair market value of such Common Shares on the date the benefit is to be included in Participant&#8217;s income.&#160; In no event will the fair market value of the Common Shares to be withheld and delivered pursuant to this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 16</u></font> exceed the minimum amount required to be withheld, unless (a) an additional amount can be withheld and not result in adverse accounting consequences, and (b) such
          additional withholding amount is authorized by the Committee.&#160; Participants will also make such arrangements as the Company may require for the payment of any withholding tax or other obligation that may arise in connection with the disposition
          of Common Shares acquired upon the exercise of Option Rights.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">17.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Compliance with Section 409A of the Code.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent applicable, it is
          intended that this Plan and any grants made hereunder comply with the provisions of Section 409A of the Code, so that the income inclusion provisions of Section 409A(a)(1) of the Code do not apply to the Participants.&#160; This Plan and any grants
          made hereunder will be administered in a manner consistent with this intent.&#160; Any reference in this Plan to Section 409A of the Code will also include any regulations or any other formal guidance promulgated with respect to such section by the
          U.S. Department of the Treasury or the Internal Revenue Service.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither a Participant nor any of a
          Participant&#8217;s creditors or beneficiaries will have the right to subject any deferred compensation (within the meaning of Section 409A of the Code) payable under this Plan and grants hereunder to any anticipation, alienation, sale, transfer,
          assignment, pledge, encumbrance, attachment or garnishment.&#160; Except as permitted under Section 409A of the Code, any deferred compensation (within the meaning of Section 409A of the Code) payable to a Participant or for a Participant&#8217;s benefit
          under this Plan and grants hereunder may not be reduced by, or offset against, any amount owed by a Participant to the Company or any of its Subsidiaries.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">17</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, at the time of a Participant&#8217;s
          separation from service (within the meaning of Section 409A of the Code), (i) the Participant will be a specified employee (within the meaning of Section 409A of the Code and using the identification methodology selected by the Company from time
          to time) and (ii) the Company makes a good faith determination that an amount payable hereunder constitutes deferred compensation (within the meaning of Section 409A of the Code) the payment of which is required to be delayed pursuant to the
          six-month delay rule set forth in Section 409A of the Code in order to avoid taxes or penalties under Section 409A of the Code, then the Company will not pay such amount on the otherwise scheduled payment date but will instead pay it, without
          interest, on the fifth business day of the seventh month after such separation from service.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Solely with respect to any award
          that constitutes nonqualified deferred compensation subject to Section 409A of the Code and that is payable on account of a Change in Control (including any installments or stream of payments that are accelerated on account of a Change in
          Control), a Change in Control shall occur only if such event also constitutes a &#8220;change in the ownership,&#8221; &#8220;change in effective control,&#8221; and/or a &#8220;change in the ownership of a substantial portion of assets&#8221; of the Company as those terms are
          defined under Treasury Regulation &#167;1.409A-3(i)(5), but only to the extent necessary to establish a time and form of payment that complies with Section 409A of the Code, without altering the definition of Change in Control for any purpose in
          respect of such award.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding any provision of
          this Plan and grants hereunder to the contrary, in light of the uncertainty with respect to the proper application of Section 409A of the Code, the Company reserves the right to make amendments to this Plan and grants hereunder as the Company
          deems necessary or desirable to avoid the imposition of taxes or penalties under Section 409A of the Code.&#160; In any case, a Participant will be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on a
          Participant or for a Participant&#8217;s account in connection with this Plan and grants hereunder (including any taxes and penalties under Section 409A of the Code), and neither the Company nor any of its affiliates will have any obligation to
          indemnify or otherwise hold a Participant harmless from any or all of such taxes or penalties.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">18.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Amendments.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board may at any time and from
          time to time amend this Plan in whole or in part; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that if an amendment to this Plan,
          for purposes of applicable stock exchange rules and except as permitted under <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 11</u></font> of this Plan, (i) would materially increase the benefits accruing
          to Participants under this Plan, (ii) would materially increase the number of securities which may be issued under this Plan, (iii) would materially modify the requirements for participation in this Plan,<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>or (iv) must otherwise be approved by the Shareholders in order to comply with applicable law or the rules of the NASDAQ Stock Market or, if the Common Shares are not traded on the NASDAQ Stock Market,
          the principal national securities exchange upon which the Common Shares are traded or quoted, all as determined by the Board, then, such amendment will be subject to Shareholder approval and will not be effective unless and until such approval
          has been obtained.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">18</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except in connection with a
          corporate transaction or event described in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 11</u></font> of this Plan or in connection with a Change in Control, the terms of outstanding awards may not be
          amended to reduce the Option Price of outstanding Option Rights or the Base Price of outstanding Appreciation Rights, or cancel outstanding &#8220;underwater&#8221; Option Rights or Appreciation Rights (including following a Participant&#8217;s voluntary surrender
          of &#8220;underwater&#8221; Option Rights or Appreciation Rights) in exchange for cash, other awards or Option Rights or Appreciation Rights with an Option Price or Base Price, as applicable, that is less than the Option Price of the original Option Rights
          or Base Price of the original Appreciation Rights, as applicable, without Shareholder approval.&#160; This <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 18(b)</u></font> is intended to prohibit the repricing of
          &#8220;underwater&#8221; Option Rights and Appreciation Rights and will not be construed to prohibit the adjustments provided for in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 11</u></font> of this Plan.&#160;
          Notwithstanding any provision of this Plan to the contrary, this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 18(b)</u></font> may not be amended without approval by the Shareholders.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt; font-size: 10pt; font-family: 'Times New Roman';"><a name="OLE_LINK1"></a>(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If permitted by Section 409A of the Code, but subject to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 18(d)</u></font>, including in the case of termination of employment or service, or in the case of unforeseeable emergency or other circumstances or in the event of a Change in Control, to the extent a
        Participant holds an Option Right or Appreciation Right not immediately exercisable in full, or any Restricted Shares as to which the substantial risk of forfeiture or the prohibition or restriction on transfer has not lapsed, or any Restricted
        Stock Units as to which the Restriction Period has not been completed, or any Cash Incentive Awards, Performance Shares or Performance Units which have not been fully earned, or any dividend equivalents or other awards made pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 9</u></font> of this Plan subject to any vesting schedule or transfer restriction, or who holds Common Shares subject to any transfer restriction imposed pursuant to
        <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 15(b)</u></font> of this Plan, the Committee may, in its sole discretion, provide for continued vesting or accelerate the time at which such Option Right,
        Appreciation Right or other award may vest or be exercised or the time at which such substantial risk of forfeiture or prohibition or restriction on transfer will lapse or the time when such Restriction Period will end or the time at which such
        Cash Incentive Awards, Performance Shares or Performance Units will be deemed to have been earned or the time when such transfer restriction will terminate or may waive any other limitation or requirement under any such award.</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 18(b)</u></font> of this Plan, the Committee may amend the terms of any award theretofore granted under this Plan prospectively or retroactively<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Except for adjustments made pursuant to </font><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 11</u></font> of this Plan, no such
          amendment will materially impair the rights of any Participant without his or her consent.&#160; The Board may, in its discretion, terminate this Plan at any time.&#160; Termination of this Plan will not affect the rights of Participants or their
          successors under any awards outstanding hereunder and not exercised in full on the date of termination.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">19.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Governing Law.&#160; </font>This Plan and all grants and awards and actions taken hereunder will be governed by and construed in accordance with the internal substantive laws of
          the State of Georgia.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">19</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">20.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Effective Date/Termination.&#160; </font>This Plan will be effective as of the Effective Date.&#160; No grants will be made on or after the Predecessor Plan Termination Date under the
          Predecessor Plan, provided that outstanding awards granted under the Predecessor Plan will continue thereafter in accordance with their terms. No grant will be made under this Plan on or after the tenth anniversary of the Effective Date, but all
          grants made prior to such date will continue in effect thereafter subject to the terms thereof and of this Plan.&#160; For clarification purposes, the terms and conditions of this Plan shall not apply to or otherwise impact previously granted and
          outstanding awards under the Predecessor Plan, as applicable (except for purposes of providing for Common Shares under such awards to be added to the aggregate number of Common Shares available under <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 3(a)(i)</u></font> of this Plan pursuant to the share counting rules of this Plan).</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">21.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Miscellaneous Provisions.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will not be required
          to issue any fractional Common Shares pursuant to this Plan.&#160; The Committee may provide for the elimination of fractions or for the settlement of fractions in cash.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Plan will not confer upon any
          Participant any right with respect to continuance of employment or other service with the Company or any Subsidiary, nor will it interfere in any way with any right the Company or any Subsidiary would otherwise have to terminate such
          Participant&#8217;s employment or other service at any time.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except with respect to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 21(e)</u></font> of this Plan, to the extent that any provision of this Plan would prevent any Option Right that was intended to qualify as an Incentive Stock
          Option from qualifying as such, that provision will be null and void with respect to such Option Right.&#160; Such provision, however, will remain in effect for other Option Rights and there will be no further effect on any provision of this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No award under this Plan may be
          exercised by the holder thereof if such exercise, and the receipt of cash or Common Shares thereunder, would be, in the opinion of counsel selected by the Company, contrary to law or the regulations of any duly constituted authority having
          jurisdiction over this Plan.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Absence on leave approved by a
          duly constituted officer of the Company or any of its Subsidiaries will not be considered interruption or termination of service of any employee for any purposes of this Plan or awards granted hereunder.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Participant will have any
          rights as a Shareholder with respect to any Common Shares subject to awards granted to him or her under this Plan prior to the date as of which he or she is actually recorded as the holder of such Common Shares upon the share records of the
          Company.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may condition the
          grant of any award or combination of awards authorized under this Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or a Subsidiary to the
          Participant.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except with respect to Option
          Rights and Appreciation Rights, the Committee may permit Participants to elect to defer the issuance of Common Shares under this Plan pursuant to such rules, procedures or programs as it may establish for purposes of this Plan and which are
          intended to comply with the requirements of Section 409A of the Code.&#160; The Committee also may provide that deferred issuances and settlements include the crediting of dividend equivalents or interest on the deferral amounts.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">20</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If any provision of this Plan is
          or becomes invalid or unenforceable in any jurisdiction, or would disqualify this Plan or any award under any law deemed applicable by the Committee, such provision will be construed or deemed amended or limited in scope to conform to applicable
          laws or, in the discretion of the Committee, it will be stricken and the remainder of this Plan will remain in full force and effect.&#160; Notwithstanding anything in this Plan or an Evidence of Award to the contrary, nothing in this Plan or in an
          Evidence of Award prevents a Participant from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding
          by any governmental authorities regarding possible legal violations, and for purpose of clarity a Participant is not prohibited from providing information voluntarily to the Securities and Exchange Commission pursuant to Section 21F of the
          Exchange Act.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">22.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">Share-Based Awards in Substitution for Awards Granted by Another Company.</font>&#160; Notwithstanding anything in this Plan to the contrary:</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Awards may be granted under this
          Plan in substitution for or in conversion of, or in connection with an assumption of, stock options, stock appreciation rights, restricted stock, restricted stock units or other share or share-based awards held by awardees of an entity engaging
          in a corporate acquisition or merger transaction with the Company or any Subsidiary.&#160; Any conversion, substitution or assumption will be effective as of the close of the merger or acquisition, and, to the extent applicable, will be conducted in a
          manner that complies with Section 409A of the Code. The awards so granted may reflect the original terms of the awards being assumed or substituted or converted for and need not comply with other specific terms of this Plan, and may account for
          Common Shares substituted for the securities covered by the original awards and the number of shares subject to the original awards, as well as any exercise or purchase prices applicable to the original awards, adjusted to account for differences
          in stock prices in connection with the transaction.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that a company
          acquired by the Company or any Subsidiary or with which the Company or any Subsidiary merges has shares available under a pre-existing plan previously approved by shareholders and not adopted in contemplation of such acquisition or merger, the
          shares available for grant pursuant to the terms of such plan (as adjusted, to the extent appropriate, to reflect such acquisition or merger) may be used for awards made after such acquisition or merger under this Plan; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that awards using such available shares may not be made after the date awards or grants could have been made
          under the terms of the pre-existing plan absent the acquisition or merger, and may only be made to individuals who were not employees or directors of the Company or any Subsidiary prior to such acquisition or merger.</font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any Common
          Shares that are issued or transferred by, or that are subject to any awards that are granted by, or become obligations of, the Company under <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Sections 22(a)</u></font>
          or <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>22(b)</u></font> of this Plan will not reduce the Common Shares available for issuance or transfer under this Plan or otherwise count against the limits contained
          in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 3</u></font> of this Plan.&#160; In addition, no Common Shares subject to an award that is granted by, or becomes an obligation of, the Company under <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Sections 22(a)</u></font> or <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>22(b)</u></font> of this Plan will be <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">added to the aggregate limit contained in </font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"><u>Section 3(a)(i)</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> of this Plan.</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Effective May 24, 2022</div>
    </div>
    <div> <font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font></div>
    <div style="text-align: center;"><br>
      <font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">21</font></div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
  <font style="font-size: 10pt; font-family: 'Times New Roman';">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aame-20220524.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://atlam.com/20220524" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:aame="http://atlam.com/20220524" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="aame-20220524_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aame-20220524_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://atlam.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aame-20220524_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aame-20220524_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://atlam.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="aame-20220524.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://atlam.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140488184829704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 24,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ATLANTIC AMERICAN CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-3722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">58-1027114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4370 Peachtree Road, N.E.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Atlanta<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">266-5500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000008177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $1.00 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AAME<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>brhc10038059_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aame-20220524.xsd" xlink:type="simple"/>
    <context id="c20220524to20220524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000008177</identifier>
        </entity>
        <period>
            <startDate>2022-05-24</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220524to20220524"
      id="Fact_74a6591d34794f04a7df799354f92c77">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220524to20220524"
      id="Fact_d24f48909f55493d9b75522b41a6a032">0000008177</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20220524to20220524"
      id="Fact_4b808ca986cc4a92a0300ef656acae88">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220524to20220524"
      id="Fact_6978224890d14ccfa1fe0138b61cd005">2022-05-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220524to20220524"
      id="Fact_4563323ed2d84047b4e0e7ca72cc2f0c">ATLANTIC AMERICAN CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220524to20220524"
      id="Fact_707136ee484d40f4ac3e86a26675f745">GA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220524to20220524"
      id="Fact_d73680a41b5f47bea3fe6f71d51ffeae">0-3722</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220524to20220524"
      id="Fact_3efcf0c43e1e4430a60f3185bff66662">58-1027114</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220524to20220524"
      id="Fact_a370db8678f44685963ca78a5c51b0f6">4370 Peachtree Road, N.E.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220524to20220524"
      id="Fact_7c1bbd9f1cad4a51bfc33be4c40678e7">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220524to20220524"
      id="Fact_851fd735accd4516b4125f377eee65d5">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220524to20220524"
      id="Fact_e4ac2eef0c0b4dcbb7274fff4a8f6de6">30319</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220524to20220524"
      id="Fact_43668d546f8d402d91406188a7ca894a">404</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220524to20220524"
      id="Fact_87aee2fd22214968b32afba08257f0bd">266-5500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220524to20220524"
      id="Fact_b41dccdf9771408aa3b7d6f5adbf738d">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220524to20220524"
      id="Fact_94d6d56f55d2455a84b3e467b9f5847a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220524to20220524"
      id="Fact_62111a35c0b94b57a16a12054995a602">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220524to20220524"
      id="Fact_03fe0a1dbe1f4111a6f6c3a38bd94f26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220524to20220524"
      id="Fact_577f0f2bb91043db9f3ca0553813f03a">Common Stock, par value $1.00 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220524to20220524"
      id="Fact_1a5b71a9da124841824c684739c9ee79">AAME</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220524to20220524"
      id="Fact_7ee2adac0843404695de13ea7dea712a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220524to20220524"
      id="Fact_d304819f6a2944dbaeacbab31fe200b0">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ 0E>_5)>*NQS     $P(
M  L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2
M!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4
M+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(
M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/I
MKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !"5[]4'#AE
MZC\!   \ @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV["0 S\E=5^0!-0BU1$
MN)0^D*H6E8K[DG6(Q3XBKP,M7U\G452D7GKR>FR-9V87YTC'?8Q']>5=2(6N
MF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,9
M2L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3 QFU+
MBLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)
M'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND
M53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R
M( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ 0E>_
M5"0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61
M/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?
M:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-D
MGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R
M&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    (
M $)7OU1ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#
M,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7
MK-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ
M*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@
M9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WC
MEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2F
MKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_F
MB^$_7G\!4$L! A0#%     @ 0E>_5 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !"5[]4],[4)^\
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $)7OU27BKL<P    !,"   +
M      "  5\/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( $)7OU0<.&7J/P$
M #P"   /              "  4@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " !"5[]4)!Z;HJT   #X 0  &@              @ &T$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !"5[]499!YDAD!  #/
M P  $P              @ &9$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  #C$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10038059_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://atlam.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10038059_8k.htm">brhc10038059_8k.htm</File>
    <File>aame-20220524.xsd</File>
    <File>aame-20220524_lab.xml</File>
    <File>aame-20220524_pre.xml</File>
    <File>brhc10038059_ex10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10038059_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10038059_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aame-20220524_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aame-20220524_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aame-20220524.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "aame",
   "nsuri": "http://atlam.com/20220524",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10038059_8k.htm",
      "contextRef": "c20220524to20220524",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://atlam.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10038059_8k.htm",
      "contextRef": "c20220524to20220524",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://atlam.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001140361-22-021173-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-021173-xbrl.zip
M4$L#!!0    ( $-7OU2MH@-*40,  &H/   1    86%M92TR,#(R,#4R-"YX
M<V2U5UMOVC 4?I^T_^#EW22!=BJHM.K4BRIUZ\0V:6^3<1RPEMB9[:SP[V<[
M. D!4A(Z\>++^2X^/G;,Y?4J3<!?(B3E;.J%@\ #A&$>4;:8>KF$2&)*O>NK
M]^\N/T#X0!@12)$(S-?@[O;A9A;31(=*\'7VK)L$7 P"\P.?!$>1H-&"0&C
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MO]V.6;B%F!YT.+/\D5E^A^NN27GF"_/E/M* C3:R9S"X@&'0+>L[[] C51W
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M3(-D48]HK]IG\L;M@.K D"87A=6[JPJYC'U"GPC-!G"?LGOW,[)FUY#7,Q+
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M[W LK<45.^+?_%LTA?DWY<[^!U!+ P04    " !#5[]48,\2Z^8%  #I/@
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M,THE0'W<1-\I[04A^@,LZN"=6M2F!%B@O#N@UB2[;JK2!P7J].]K[Y!^[FY
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MQ+UJM9!7\7,=)4>7!.SH!W.:3GN=)D$!1S9]"IFIWC*2L&(8I:0&+5E-?0+
M%EQ(KFXK-/US55YD\\R0&6%G^@62UOD0$/EIC76K3W?77%S<<]=8OHRMA%J*
M>RJ5#[95IKU;19GG.CUD(O\!3H2J"4-2#(:?H->C2$R+U)!P692%GI! $G&$
M].EN'O B=A!3=B:O*Z;<P63CQH$]%%'WQJ1PJ2TS)Y-8/9 P7S;C -[2%]F2
M3W=+_/GG+K:$PVL82A7'._6P>GZKU_**:AHMJML[ZT]W^C]^_ QQ_GX-QFS[
MT#DEVJT,1R>0KG2:D!-S$ZQ6N_L\,;>KS#L<XTNEMW_&)#W7[7@M[_U.Y9QB
M;-_TZ:YHGN_D0'E]]=SD>6+]5B\(E-@TKM=)&8-D=**HD=_)X'OBO*04KHLH
MJME.1/O0HDZ/3/!.MR@V.OFR;*2)V5':7J5J==,ZAWB+BA8H*\U0RN;Z.!**
MT8HBLJP,TE+6A)HE@K*;!^=;?BJJ0EA?P0T,A2[UJ"^R=>S7&<2&)C//-"=*
MHA'PFP*#J0H^CYV5ZU+O7O-2-5R.T%:>YF/F3^F;Z"LU"$ODW#.S2PG?I#@>
MS/%*?$3X>$)%&]Q5P>83/*N7ESH#[5@PTP(:0>0.Q_3P5#464W'0?I9XFXW
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M8@!L&VC>$LHE.+7\E1E"B_H$]M8B*Q22#"8#SG*=68ZNMV6TD@R17P1C-.&
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MFJDSC 2A"K$;!JU>J'$B!Z(!,Z@YE6P;D+$ #EO&^V;1X0WC&U.//"8%],$
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MO-FAC\$7UQ*XTCQM)!-WJ@]/^Q'H';Q>VMCO&ZD;D\:JUM5F9;"!G"+YLK[
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M^>,/\S*]IA\NFE4./_Q_4$L! A0#%     @ 0U>_5*VB TI1 P  :@\  !$
M             ( !     &%A;64M,C R,C U,C0N>'-D4$L! A0#%     @
M0U>_5/.$* 6!"   <E@  !4              ( !@ ,  &%A;64M,C R,C U
M,C1?;&%B+GAM;%!+ 0(4 Q0    ( $-7OU1@SQ+KY@4  .D^   5
M      "  30,  !A86UE+3(P,C(P-3(T7W!R92YX;6Q02P$"% ,4    " !#
M5[]4ZF(-JY 7  !*W@  $P              @ %-$@  8G)H8S$P,#,X,#4Y
M7SAK+FAT;5!+ 0(4 Q0    ( $-7OU24G3Q07%0  *E% @ 7
M  "  0XJ  !B<FAC,3 P,S@P-3E?97@Q,"TQ+FAT;5!+!08     !0 % $L!
(  "??@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
